DK0401056T4 - Glutamin til behandling af nedsat værtsforsvar - Google Patents

Glutamin til behandling af nedsat værtsforsvar

Info

Publication number
DK0401056T4
DK0401056T4 DK90306062T DK90306062T DK0401056T4 DK 0401056 T4 DK0401056 T4 DK 0401056T4 DK 90306062 T DK90306062 T DK 90306062T DK 90306062 T DK90306062 T DK 90306062T DK 0401056 T4 DK0401056 T4 DK 0401056T4
Authority
DK
Denmark
Prior art keywords
glutamine
treatment
host defense
impaired host
gut
Prior art date
Application number
DK90306062T
Other languages
English (en)
Other versions
DK0401056T3 (da
Inventor
Robert J Smith
Douglas W Wilmore
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23419606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0401056(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK0401056T3 publication Critical patent/DK0401056T3/da
Publication of DK0401056T4 publication Critical patent/DK0401056T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Looms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Packaging Of Machine Parts And Wound Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Seasonings (AREA)
DK90306062T 1989-06-02 1990-06-04 Glutamin til behandling af nedsat værtsforsvar DK0401056T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36083989A 1989-06-02 1989-06-02

Publications (2)

Publication Number Publication Date
DK0401056T3 DK0401056T3 (da) 1998-07-27
DK0401056T4 true DK0401056T4 (da) 2007-07-16

Family

ID=23419606

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90306062T DK0401056T4 (da) 1989-06-02 1990-06-04 Glutamin til behandling af nedsat værtsforsvar

Country Status (16)

Country Link
EP (1) EP0401056B2 (da)
JP (4) JP3068644B2 (da)
KR (1) KR0178799B1 (da)
AT (1) ATE160089T1 (da)
AU (1) AU641403B2 (da)
DE (1) DE69031694T3 (da)
DK (1) DK0401056T4 (da)
ES (1) ES2111529T5 (da)
FI (1) FI915677A0 (da)
GR (1) GR3025678T3 (da)
HU (1) HU220214B (da)
IL (1) IL94549A (da)
NO (1) NO914730D0 (da)
PT (1) PT94223B (da)
WO (1) WO1990014823A1 (da)
ZA (1) ZA904151B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH0569836U (ja) * 1992-02-25 1993-09-21 松下電工株式会社 ピアノハンドル式スイッチ
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
EP0738146B1 (en) 1994-01-11 2003-05-02 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
JP5473190B2 (ja) * 2003-10-16 2014-04-16 ネステク ソシエテ アノニム 化学療法又は放射線療法の副作用に対する栄養組成物
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
CA2673054C (en) * 2006-12-15 2016-05-10 Tima Foundation Novel compositions and uses thereof
EP2612560A1 (en) 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction

Also Published As

Publication number Publication date
HUT61193A (en) 1992-12-28
ES2111529T5 (es) 2007-11-16
EP0401056A3 (en) 1991-09-25
JP2000198733A (ja) 2000-07-18
EP0401056B2 (en) 2007-06-13
EP0401056B1 (en) 1997-11-12
JP3113876B2 (ja) 2000-12-04
GR3025678T3 (en) 1998-03-31
JP2000186034A (ja) 2000-07-04
NO914730D0 (no) 1991-12-02
AU5827190A (en) 1991-01-07
JP3113877B2 (ja) 2000-12-04
JPH05500655A (ja) 1993-02-12
HU220214B (hu) 2001-11-28
IL94549A (en) 1996-08-04
DE69031694T2 (de) 1998-03-12
EP0401056A2 (en) 1990-12-05
JP3068644B2 (ja) 2000-07-24
PT94223B (pt) 1997-04-30
DE69031694D1 (de) 1997-12-18
JP3113878B2 (ja) 2000-12-04
KR920700629A (ko) 1992-08-10
WO1990014823A1 (en) 1990-12-13
IL94549A0 (en) 1991-03-10
ZA904151B (en) 1991-03-27
ES2111529T3 (es) 1998-03-16
ATE160089T1 (de) 1997-11-15
FI915677A0 (fi) 1991-12-02
DE69031694T3 (de) 2007-10-18
KR0178799B1 (ko) 1999-03-20
DK0401056T3 (da) 1998-07-27
JP2000186035A (ja) 2000-07-04
AU641403B2 (en) 1993-09-23
PT94223A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
DK0401056T3 (da) Glutamin til behandling af nedsat værtsforsvar.
DK0862865T3 (da) Behandling af tobak
DK0635270T3 (da) Parathyreideahormon og raloxifen til forøgelse af knoglemasse
DE69111752D1 (de) Wiederaufschmelzlötofen.
AR240255A1 (es) Un metodo de preservacion de virus vivos.
NO931423L (no) Fremgangsmaater og anvendelser for effektive genetiske suppressor-elementer
DE69104652D1 (de) Wiederaufschmelzlötofen.
DK214682A (da) Fremgangsmaade og apparat til behandling af afgroede
ATE33558T1 (de) Stabilisierung von influenzavirusimpfstoffen.
FR2719659B1 (fr) Procédé et dispositif de correction de la trajectoire de projectiles.
DK0552240T3 (da) Ny metode til behandling af depression
DK54090D0 (da) Fremgangsmaade og apparat til fremstilling af krumme formstofboejler, isaer busteholderboejler
IT1133069B (it) Procedimento e dispositivo per l estrazione e trattamento di materie solide da soluzioni o sospensioni particolarmente da acque di macellazione a scopo di ricupero
DK0681470T3 (da) Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf
FR2791495B1 (fr) Procede de synchronisation de rythme d'un signal numerique
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
NO891494D0 (no) Sett eller spill for komposisjon av tall, former og moenstre.
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
DE69014057D1 (de) Verfahren zur Schmelzreduktion von Metallen und Schmelzreduktionsofen.
DE69111324D1 (de) Vorrichtung zur Behandlung oder Trennung von Gasen.
CA2057055A1 (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
DK0469348T3 (da) cDNA-sekvens og detektering af hepatitis C-virus
ATE283366T1 (de) Verfahren zur verwendung von viraler replicase
DK154787A (da) Fremgangsmaade til ekstraktion af paraffiner fra blandinger af paraffiner og alkansulfonsyrer.
DK384387A (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus